John Markey - Net Worth and Insider Trading

John Markey Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Markey owns 1 companies in total, including Sonnet BioTherapeutics Holdings Inc (SONN) .

Click here to see the complete history of John Markey’s form 4 insider trades.

Insider Ownership Summary of John Markey

Ticker Comapny Transaction Date Type of Owner
SONN Sonnet BioTherapeutics Holdings Inc 2023-08-07 10 percent owner

John Markey Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Markey Ownership Network

Ownership Network List of John Markey

No Data

Ownership Network Relation of John Markey

Insider Network Chart

John Markey Owned Company Details

What does Sonnet BioTherapeutics Holdings Inc do?

Who are the key executives at Sonnet BioTherapeutics Holdings Inc?

John Markey is the 10 percent owner of Sonnet BioTherapeutics Holdings Inc. Other key executives at Sonnet BioTherapeutics Holdings Inc include Chief Technical Officer Susan Dexter , director & Chairman & President and CEO Pankaj Mohan , and Chief Medical Officer Richard T Kenney .

Sonnet BioTherapeutics Holdings Inc (SONN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sonnet BioTherapeutics Holdings Inc (SONN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sonnet BioTherapeutics Holdings Inc (SONN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sonnet BioTherapeutics Holdings Inc Insider Transactions

No Available Data

John Markey Mailing Address

Above is the net worth, insider trading, and ownership report for John Markey. You might contact John Markey via mailing address: 10096 Ridgewood Drive, Twinsburg Oh 44087.

Discussions on John Markey

No discussions yet.